Engineering synthetically modified insulin for glucose-responsive diabetes therapy
Though a suite of different insulin variants have been used clinically to provide greater control over pharmacokinetics, no clinically used insulin can tune its potency and/or bioavailability in a glucose-dependent manner. In order to improve therapy for diabetic patients, a vision has been the deve...
Main Authors: | , , |
---|---|
Other Authors: | , , , , |
Format: | Article |
Language: | English |
Published: |
Informa UK Limited,
2019-08-23T14:26:54Z.
|
Subjects: | |
Online Access: | Get fulltext |